Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma

Journal of Nuclear Medicine

Volumn 49, Issue 12, 2008, Pages 1952-1957

  Chen, Libo ^a   Luo, Quanyong ^a   Shen, Yan ^a   Yu, Yongli ^a   Yuan, Zhibin ^a   Lu, Hankui ^a   Zhu, Ruisen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

131I; Fusion image; SPECT CT; Thyroid carcinoma

Indexed keywords

IODINE 131; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOLOGIST; SCHOOL CHILD; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING; CHILD; IMAGE SUBTRACTION; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 57149085286     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.052399     Document Type: Article

References (28)

1. 67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma. Eur J Nucl Med Mol Imaging. 2005;32:1011-1017.
2. Mar MV, Miller SA, Kim EE, Macapinlac HA. Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. J Nucl Med Technol. 2007;35:10-16.
3. 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587-594.
4. 99mTc- sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46:248-252.
5. Amthauer H, Denecke T, Rohlfing T, et al. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours. Eur Radiol. 2005;15:1456-1462.
6. 111Inpentetreotide in assessment of neuroendocrine tumours. Clin Endocrinol (Oxf). 2003;59:565-573.
7. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007;48:201-206.
8. Horger M, Eschmann SM, Pfannenberg C, et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2003;30:1665-1673.
9. 99mTc-HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47:1908-1913.
10. 131I SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med. 2003;44:1905-1910.
11. Wiest R, Kassubek J, Schindler K, et al. Comparison of voxel-based 3-D MRI analysis and subtraction ictal SPECT coregistered to MRI in focal epilepsy. Epilepsy Res. 2005;65:125-133.
12. Pietrzyk U, Herholz K, Fink G, et al. An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. J Nucl Med. 1994;35:2011-2018.
13. Bocher M, Balan A, Krausz Y, et al. Gamma camera-mounted anatomical x-ray tomography: technology, system characteristics and first images. Eur J Nucl Med. 2000;27:619-627.
14. Lind P, Kohlfürst S. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer. Semin Nucl Med. 2006;36:194-205.
15. Cohen JB, Kalinyak JE, McDougall IR. Modern management of differentiated thyroid cancer. Cancer Biother Radiopharm. 2003;18:689-705.
16. Nishiyama RH. Overview of surgical pathology of the thyroid gland. World J Surg. 2000;24:898-906.
17. 131I whole body scintigraphy in thyroid cancer patients. Q J Nucl Med. 1999;43:188-194.
18. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg. 2007;31:895-904.
19. Ito Y, Miyauchi A. Lateral and mediastinal lymph node dissection in differentiated thyroid carcinoma: indications, benefits, and risks. World J Surg. 2007;31:905-915.
20. Stojadinovic A, Shoup M, Ghossein RA, et al. The role of operations for distantly metastatic well-differentiated thyroid carcinoma. Surgery. 2002;131:636-643.
21. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer. 2007;110:1451-1456.
22. 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2004;31:1435-1442.
23. Ruf J, Lehmkuhl L, Bertram H, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun. 2004;25:1177-1182.
24. Macdonald W, Armstrong J. Benign struma ovarii in a patient with invasive papillary thyroid cancer: detection with I-131 SPECT-CT. Clin Nucl Med. 2007;32:380-382.
25. von Falck C, Beer G, Gratz KF, Galanski M. Renal metastases from follicular thyroid cancer on SPECT/CT. Clin Nucl Med. 2007;32:751-752.
26. Kienast O, Hofmann M, Ozer S, Dobrozemsky G, Dudczak R, Kurtaran A. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding. Thyroid. 2003;13:509-510.
27. Karavitaki N, Vlassopoulou V, Tzanela M, Tzavara I, Thalassinos N. Recurrent and/or metastatic thyroid cancer: therapeutic options. Expert Opin Pharmacother. 2002;3:939-947.
28. Schillaci O. SPECT/CT: a new era for SPECT imaging? Eur J Nucl Med Mol Imaging. 2005;32:521-524.